Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $174.16M | -70.90% | -61.80% | -66.90% | -88.60% | 0.14 | 7.92 | N/A | N/A | N/A | ||
| ATOS | ATOSSA THERAPEUTICS INC | $19.89M | -84.90% | -72.40% | -123.47% | 2,579.00% | 0.25 | 4.92 | N/A | N/A | N/A | ||
| ALM | ALMONTY INDUSTRIES INC | $3.49B | -116.10% | -40.00% | -30.51% | -37.20% | 0.65 | 3.89 | 7.30% | -498.00% | -484.13% | ||
| FTH | FAETH THERAPEUTICS INC | $34.22M | N/A | -256.50% | -96.47% | -879.10% | -0.10 | 14.39 | N/A | N/A | N/A | ||
| OSTX | OS THERAPIES INC | $72.60M | N/A | -422.40% | 364.62% | 417.70% | -1.58 | 0.05 | N/A | N/A | N/A | ||
| DSGN | DESIGN THERAPEUTICS INC | $826.08M | -34.00% | -32.10% | -34.72% | -36.00% | 0.07 | 18.86 | N/A | N/A | N/A | ||
| VOR | VOR BIOPHARMA INC | $1.21B | N/A | -261.20% | -179.97% | -1,096.00% | -4.37 | 31.15 | N/A | N/A | N/A | ||
| WHWK | WHITEHAWK THERAPEUTICS INC | $204.73M | -79.60% | -74.00% | -99.68% | -141.90% | 0.10 | 11.36 | N/A | N/A | N/A | ||
| ASST | STRIVE INC | $907.69M | N/A | N/A | N/A | N/A | 0.04 | 11.44 | N/A | N/A | N/A | ||
| LONA | LEONABIO INC | $71.95M | -381.00% | -225.70% | -199.33% | -1,888.60% | 0.45 | 10.38 | N/A | N/A | N/A | ||
| BIOA | BIOAGE LABS INC | $497.87M | -29.40% | -27.30% | -23.43% | -90.50% | 0.05 | 24.76 | 100.00% | -871.80% | -867.09% | ||
| BNTX | BIONTECH SE | $23.10B | -6.70% | -5.80% | -5.83% | -12.80% | 0.13 | 8.80 | 77.60% | -44.60% | -40.14% | ||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $265.09M | -124.10% | -85.60% | -55.23% | -128.90% | 0.18 | 7.21 | N/A | N/A | N/A | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $778.22M | -25.90% | -22.80% | -24.27% | -23.30% | 0.21 | 1.10 | 79.00% | -49.40% | -47.66% | ||
| SKHY | SK HYNIX INC | N/A | N/A | N/A | N/A | N/A | 0.36 | 2.62 | N/A | N/A | N/A | ||
| QNCX | QUINCE THERAPEUTICS INC | $22.34M | N/A | -38.10% | -197.19% | -215.70% | 0.70 | 2.92 | N/A | N/A | N/A | ||
| DEFT | DEFI TECHNOLOGIES INC | $182.64M | 30.50% | 4.20% | 26.40% | 321.00% | 3.06 | 1.10 | 45.10% | 56.40% | 63.19% | ||
| GT | GOODYEAR TIRE & RUBBER CO | $2.07B | -57.50% | -10.40% | -0.17% | -0.10% | 5.09 | 1.04 | 18.60% | -11.50% | -0.11% | ||
| LTRX | LANTRONIX INC | $242.88M | -8.80% | -5.40% | -7.35% | -14.30% | 0.61 | 2.74 | 42.90% | -5.50% | -5.69% | ||
| AVAV | AEROVIRONMENT INC | $8.55B | -6.10% | -4.70% | -5.35% | -13.10% | 0.30 | 4.30 | 25.30% | -13.40% | -14.29% | ||
| ORIC | ORIC PHARMACEUTICALS INC | $1.40B | -35.40% | -33.40% | -36.56% | -39.70% | 0.06 | 13.19 | N/A | N/A | N/A | ||
| XE | X-ENERGY INC | $5.34B | N/A | N/A | N/A | N/A | -0.11 | 8.67 | N/A | N/A | N/A | ||
| CPS | COOPER-STANDARD HOLDINGS INC | $546.15M | N/A | -2.10% | 4.77% | 2.80% | -17.14 | 1.40 | 12.10% | -1.40% | 2.09% | ||
| SGP | SPYGLASS PHARMA INC | $806.08M | N/A | N/A | N/A | N/A | 0.03 | 38.00 | N/A | N/A | N/A | ||
| VIA | VIA TRANSPORTATION INC | $1.78B | N/A | N/A | N/A | N/A | 0.16 | 5.09 | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.